adplus-dvertising
Close Menu
Breaking News:
Subscribe
Health News Harry MillerBy

Merck initiates rolling submission to Health Canada for oral COVID-19 drug

Merck initiates rolling submission to Health Canada for oral COVID-19 drug

U.S. drugmaker Merck & Co Inc has initiated a rolling submission to Health Canada for Molnupiravir, an oral antiviral therapy treatment for COVID-19, it said in a statement on Friday.

Molnupiravir is being developed by Merck and Ridgeback Biotherapeutics for the treatment of non-hospitalized COVID-19 patients.

 

(Reporting by Juby Babu in Bengaluru; Editing by Leslie Adler)

Share.

Harry Miller is a writer and editor based in Toronto with 14 years of experience in the journalism industry. Before joining Canada News Media as a National Online Journalist, Miller worked as a senior writer and a reporter-editor with the Canadian Press and as a breaking news reporter with the Toronto Star. At Canada News Media he covers national news and the trending stories Canadians are searching for. Miller holds two bachelor's degrees, one in journalism from Ryerson University and another in communications and film studies from Carleton University.

Related Posts